{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:43:48Z","timestamp":1789231428509,"version":"build-2803163510"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01766-x","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T04:02:46Z","timestamp":1647576166000},"page":"1609-1623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones"],"prefix":"10.1007","volume":"45","author":[{"given":"K.","family":"Pafili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Armeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1488-2668","authenticated-orcid":false,"given":"I.","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"1766_CR1","doi-asserted-by":"publisher","first-page":"154299","DOI":"10.1016\/j.metabol.2020.154299","volume":"111S","author":"B Dewidar","year":"2020","unstructured":"Dewidar B et al (2020) Metabolic liver disease in diabetes\u2014from mechanisms to clinical trials. Metabolism 111S:154299","journal-title":"Metabolism"},{"issue":"3","key":"1766_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/14656566.2017.1413346","volume":"19","author":"K Pafili","year":"2018","unstructured":"Pafili K, Maltezos E, Papanas N (2018) Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won? Expert Opin Pharmacother 19(3):185\u2013187","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"1766_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cld.2017.08.006","volume":"22","author":"NT Gunn","year":"2018","unstructured":"Gunn NT, Shiffman ML (2018) The use of liver biopsy in nonalcoholic fatty liver disease: when to biopsy and in whom. Clin Liver Dis 22(1):109\u2013119","journal-title":"Clin Liver Dis"},{"key":"1766_CR4","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","volume":"50","author":"K Pafili","year":"2020","unstructured":"Pafili K, Roden M (2020) Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol Metab 50:101122","journal-title":"Mol Metab"},{"issue":"4","key":"1766_CR5","doi-asserted-by":"publisher","first-page":"e94059","DOI":"10.1371\/journal.pone.0094059","volume":"9","author":"S Kahl","year":"2014","unstructured":"Kahl S et al (2014) Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. PLoS ONE 9(4):e94059","journal-title":"PLoS ONE"},{"key":"1766_CR6","doi-asserted-by":"publisher","first-page":"154259","DOI":"10.1016\/j.metabol.2020.154259","volume":"111S","author":"MT Long","year":"2020","unstructured":"Long MT, Gandhi S, Loomba R (2020) Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Metabolism 111S:154259","journal-title":"Metabolism"},{"issue":"8","key":"1766_CR7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.metabol.2015.12.009","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"Polyzos SA, Mantzoros CS (2016) Nonalcoholic fatty future disease. Metabolism 65(8):1007\u20131016","journal-title":"Metabolism"},{"issue":"22","key":"1766_CR8","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.2174\/13816128113196660676","volume":"20","author":"I Gouni-Berthold","year":"2014","unstructured":"Gouni-Berthold I, Papanas N, Maltezos E (2014) The role of oral antidiabetic agents and incretin mimetics in type 2 diabetic patients with non-alcoholic fatty liver disease. Curr Pharm Des 20(22):3705\u20133715","journal-title":"Curr Pharm Des"},{"issue":"9","key":"1766_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","volume":"7","author":"OP Zaharia","year":"2019","unstructured":"Zaharia OP et al (2019) Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 7(9):684\u2013694","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7500","key":"1766_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/509282a","volume":"509","author":"JA Clayton","year":"2014","unstructured":"Clayton JA, Collins FS (2014) Policy: NIH to balance sex in cell and animal studies. Nature 509(7500):282\u2013283","journal-title":"Nature"},{"issue":"8","key":"1766_CR11","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/ijerph17082620","volume":"17","author":"P Kur","year":"2020","unstructured":"Kur P et al (2020) Sex hormone-dependent physiology and diseases of liver. Int J Environ Res Public Health 17(8):2620","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"1766_CR12","doi-asserted-by":"publisher","first-page":"e96305","DOI":"10.1371\/journal.pone.0096305","volume":"9","author":"L Fernandez-Perez","year":"2014","unstructured":"Fernandez-Perez L et al (2014) Lipid profiling and transcriptomic analysis reveals a functional interplay between estradiol and growth hormone in liver. PLoS ONE 9(5):e96305","journal-title":"PLoS ONE"},{"key":"1766_CR13","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/nrdp.2015.4","volume":"1","author":"SR Davis","year":"2015","unstructured":"Davis SR et al (2015) Menopause. Nat Rev Dis Primers 1:15004","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1766_CR14","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1530\/EJE-14-0468","volume":"172","author":"MC Markopoulos","year":"2015","unstructured":"Markopoulos MC et al (2015) Hyperandrogenism after menopause. Eur J Endocrinol 172(2):R79-91","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1766_CR15","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A et al (2019) Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology 70(4):1457\u20131469","journal-title":"Hepatology"},{"issue":"5","key":"1766_CR16","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jhep.2014.11.041","volume":"62","author":"S Ryu","year":"2015","unstructured":"Ryu S et al (2015) Age at menarche and non-alcoholic fatty liver disease. J Hepatol 62(5):1164\u20131170","journal-title":"J Hepatol"},{"issue":"12","key":"1766_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/ped.13422","volume":"59","author":"KH Yi","year":"2017","unstructured":"Yi KH et al (2017) Early menarche is associated with non-alcoholic fatty liver disease in adulthood. Pediatr Int 59(12):1270\u20131275","journal-title":"Pediatr Int"},{"issue":"1","key":"1766_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/1753-0407.12379","volume":"9","author":"J Lu","year":"2017","unstructured":"Lu J et al (2017) Age at menarche is associated with the prevalence of non-alcoholic fatty liver disease later in life. J Diabetes 9(1):53\u201360","journal-title":"J Diabetes"},{"issue":"6","key":"1766_CR19","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cgh.2020.08.012","volume":"19","author":"J Wang","year":"2021","unstructured":"Wang J et al (2021) Associations between reproductive and hormone-related factors and risk of nonalcoholic fatty liver disease in a multiethnic population. Clin Gastroenterol Hepatol 19(6):1258-1266e1","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1766_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/oby.20950","volume":"23","author":"NT Mueller","year":"2015","unstructured":"Mueller NT et al (2015) Earlier menarche is associated with fatty liver and abdominal ectopic fat in midlife, independent of young adult BMI: the CARDIA study. Obesity (Silver Spring) 23(2):468\u2013474","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"1766_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ajg.2016.57","volume":"111","author":"VH Ajmera","year":"2016","unstructured":"Ajmera VH et al (2016) Gestational diabetes mellitus is strongly associated with non-alcoholic fatty liver disease. Am J Gastroenterol 111(5):658\u2013664","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"1766_CR22","doi-asserted-by":"publisher","first-page":"107401","DOI":"10.1016\/j.jdiacomp.2019.06.006","volume":"33","author":"A Lavrentaki","year":"2019","unstructured":"Lavrentaki A et al (2019) Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis. J Diabetes Complicat 33(10):107401","journal-title":"J Diabetes Complicat"},{"issue":"5","key":"1766_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/jdi.13411","volume":"12","author":"S Kubihal","year":"2021","unstructured":"Kubihal S et al (2021) Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. J Diabetes Investig 12(5):877\u2013885","journal-title":"J Diabetes Investig"},{"issue":"3","key":"1766_CR24","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00125-010-2009-0","volume":"54","author":"S Forbes","year":"2011","unstructured":"Forbes S et al (2011) Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes. Diabetologia 54(3):641\u2013647","journal-title":"Diabetologia"},{"issue":"1","key":"1766_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/AOG.0000000000000565","volume":"125","author":"LK Endres","year":"2015","unstructured":"Endres LK et al (2015) Postpartum weight retention risk factors and relationship to obesity at 1 year. Obstet Gynecol 125(1):144\u2013152","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1766_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-019-02085-7","volume":"67","author":"SA Paschou","year":"2020","unstructured":"Paschou SA et al (2020) Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Endocrine 67(1):1\u20138","journal-title":"Endocrine"},{"issue":"4","key":"1766_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s42000-019-00135-3","volume":"13","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA et al (2014) Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis. Hormones (Athens) 13(4):519\u2013531","journal-title":"Hormones (Athens)"},{"issue":"1","key":"1766_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/humrep\/dep380","volume":"25","author":"E Vassilatou","year":"2010","unstructured":"Vassilatou E et al (2010) Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Hum Reprod 25(1):212\u2013220","journal-title":"Hum Reprod"},{"issue":"5","key":"1766_CR29","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/oby.2010.232","volume":"19","author":"I Lambrinoudaki","year":"2011","unstructured":"Lambrinoudaki I et al (2011) Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI. Obesity (Silver Spring) 19(5):988\u2013993","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"1766_CR30","first-page":"952","volume":"81","author":"P Moghetti","year":"1996","unstructured":"Moghetti P et al (1996) The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 81(3):952\u2013960","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1766_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ajg.2017.44","volume":"112","author":"M Sarkar","year":"2017","unstructured":"Sarkar M et al (2017) Testosterone levels in pre-menopausal women are associated with nonalcoholic fatty liver disease in midlife. Am J Gastroenterol 112(5):755\u2013762","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"1766_CR32","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1089\/jwh.2018.7263","volume":"28","author":"JM Park","year":"2019","unstructured":"Park JM et al (2019) Serum testosterone level within normal range is positively associated with nonalcoholic fatty liver disease in premenopausal but not postmenopausal women. J Womens Health (Larchmt) 28(8):1077\u20131082","journal-title":"J Womens Health (Larchmt)"},{"issue":"6","key":"1766_CR33","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.cgh.2020.09.045","volume":"19","author":"MA Sarkar","year":"2021","unstructured":"Sarkar MA et al (2021) Testosterone is associated with nonalcoholic steatohepatitis and fibrosis in premenopausal women with NAFLD. Clin Gastroenterol Hepatol 19(6):1267-1274e1","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"1766_CR34","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1007\/s11695-021-05663-9","volume":"31","author":"D Dilimulati","year":"2021","unstructured":"Dilimulati D et al (2021) correlation between sex hormones and non-alcoholic fatty liver disease before and after laparoscopic sleeve gastrectomy. Obes Surg 31(11):4901\u20134910","journal-title":"Obes Surg"},{"issue":"2","key":"1766_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/GME.0000000000000500","volume":"23","author":"K Matsuo","year":"2016","unstructured":"Matsuo K et al (2016) Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. Menopause 23(2):189\u2013196","journal-title":"Menopause"},{"issue":"7","key":"1766_CR36","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.fertnstert.2016.09.018","volume":"106","author":"PM Sarrel","year":"2016","unstructured":"Sarrel PM, Sullivan SD, Nelson LM (2016) Hormone replacement therapy in young women with surgical primary ovarian insufficiency. Fertil Steril 106(7):1580\u20131587","journal-title":"Fertil Steril"},{"issue":"11","key":"1766_CR37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41574-021-00538-6","volume":"17","author":"P Lefebvre","year":"2021","unstructured":"Lefebvre P, Staels B (2021) Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease. Nat Rev Endocrinol 17(11):662\u2013670","journal-title":"Nat Rev Endocrinol"},{"key":"1766_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","volume":"1043","author":"BT Palmisano","year":"2017","unstructured":"Palmisano BT, Zhu L, Stafford JM (2017) Role of estrogens in the regulation of liver lipid metabolism. Adv Exp Med Biol 1043:227\u2013256","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"1766_CR39","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1210\/clinem\/dgaa574","volume":"105","author":"NT Mueller","year":"2020","unstructured":"Mueller NT et al (2020) Sex hormone relations to histologic severity of pediatric nonalcoholic fatty liver disease. J Clin Endocrinol Metab 105(11):3496\u20133504","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1766_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","volume":"16","author":"V Jaruvongvanich","year":"2017","unstructured":"Jaruvongvanich V et al (2017) Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann Hepatol 16(3):382\u2013394","journal-title":"Ann Hepatol"},{"issue":"10","key":"1766_CR41","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","volume":"38","author":"S Kojima","year":"2003","unstructured":"Kojima S et al (2003) Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 38(10):954\u2013961","journal-title":"J Gastroenterol"},{"issue":"9","key":"1766_CR42","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10654-019-00526-1","volume":"34","author":"AA Florio","year":"2019","unstructured":"Florio AA et al (2019) Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink. Eur J Epidemiol 34(9):871\u2013878","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1766_CR43","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1038\/s41598-020-66931-9","volume":"10","author":"T Bao","year":"2020","unstructured":"Bao T et al (2020) Association between serum uric acid and nonalcoholic fatty liver disease in nonobese postmenopausal women: a cross-sectional study. Sci Rep 10(1):10072","journal-title":"Sci Rep"},{"issue":"1","key":"1766_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GME.0000000000001419","volume":"27","author":"SH Hong","year":"2020","unstructured":"Hong SH et al (2020) Comparison of anthropometric indices for the screening of nonalcoholic fatty liver disease in pre- and postmenopausal women. Menopause 27(1):88\u201394","journal-title":"Menopause"},{"issue":"14","key":"1766_CR45","doi-asserted-by":"publisher","first-page":"e19529","DOI":"10.1097\/MD.0000000000019529","volume":"99","author":"HB Kim","year":"2020","unstructured":"Kim HB, Lee YJ (2020) Association of resting heart rate with nonalcoholic fatty liver disease in postmenopausal women. Medicine (Baltimore) 99(14):e19529","journal-title":"Medicine (Baltimore)"},{"key":"1766_CR46","doi-asserted-by":"publisher","first-page":"2763093","DOI":"10.1155\/2019\/2763093","volume":"2019","author":"Y Chen","year":"2019","unstructured":"Chen Y et al (2019) Association between serum uric acid and non-alcoholic fatty liver disease according to different menstrual status groups. Can J Gastroenterol Hepatol 2019:2763093","journal-title":"Can J Gastroenterol Hepatol"},{"key":"1766_CR47","first-page":"131528","volume":"2015","author":"GE Chung","year":"2015","unstructured":"Chung GE et al (2015) The influence of metabolic factors for nonalcoholic fatty liver disease in women. Biomed Res Int 2015:131528","journal-title":"Biomed Res Int"},{"issue":"4","key":"1766_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1665-2681(19)31616-3","volume":"9","author":"Y Gutierrez-Grobe","year":"2010","unstructured":"Gutierrez-Grobe Y et al (2010) Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol 9(4):402\u2013409","journal-title":"Ann Hepatol"},{"issue":"2","key":"1766_CR49","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000346202","volume":"62","author":"SS Moon","year":"2013","unstructured":"Moon SS (2013) Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women. Ann Nutr Metab 62(2):158\u2013163","journal-title":"Ann Nutr Metab"},{"key":"1766_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejogrb.2015.04.017","volume":"190","author":"S Ryu","year":"2015","unstructured":"Ryu S et al (2015) Menopausal stages and non-alcoholic fatty liver disease in middle-aged women. Eur J Obstet Gynecol Reprod Biol 190:65\u201370","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"1766_CR51","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/gut.2006.115345","volume":"56","author":"H Volzke","year":"2007","unstructured":"Volzke H et al (2007) Menopausal status and hepatic steatosis in a general female population. Gut 56(4):594\u2013595","journal-title":"Gut"},{"issue":"12","key":"1766_CR52","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cgh.2010.08.005","volume":"8","author":"A Suzuki","year":"2010","unstructured":"Suzuki A et al (2010) Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 8(12):1062\u20131069","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"1766_CR53","doi-asserted-by":"publisher","first-page":"e124865","DOI":"10.1172\/jci.insight.124865","volume":"4","author":"GA Greendale","year":"2019","unstructured":"Greendale GA et al (2019) Changes in body composition and weight during the menopause transition. JCI Insight 4(5):e124865","journal-title":"JCI Insight"},{"issue":"1","key":"1766_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/09513590.2017.1344208","volume":"34","author":"I Lambrinoudaki","year":"2018","unstructured":"Lambrinoudaki I et al (2018) The metabolic syndrome is associated with carotid atherosclerosis and arterial stiffness in asymptomatic, nondiabetic postmenopausal women. Gynecol Endocrinol 34(1):78\u201382","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"1766_CR55","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/13697137.2012.707385","volume":"15","author":"SR Davis","year":"2012","unstructured":"Davis SR et al (2012) Understanding weight gain at menopause. Climacteric 15(5):419\u2013429","journal-title":"Climacteric"},{"issue":"8","key":"1766_CR56","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00019501-199809080-00006","volume":"9","author":"A Tchernof","year":"1998","unstructured":"Tchernof A et al (1998) Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron Artery Dis 9(8):503\u2013511","journal-title":"Coron Artery Dis"},{"issue":"7","key":"1766_CR57","first-page":"2378","volume":"85","author":"M Brochu","year":"2000","unstructured":"Brochu M et al (2000) Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab 85(7):2378\u20132384","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1766_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.maturitas.2005.03.001","volume":"53","author":"SS Signorelli","year":"2006","unstructured":"Signorelli SS et al (2006) Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53(1):77\u201382","journal-title":"Maturitas"},{"issue":"1","key":"1766_CR59","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/ijms21010314","volume":"21","author":"AR Bourgonje","year":"2020","unstructured":"Bourgonje AR et al (2020) Systemic oxidative stress is increased in postmenopausal women and independently associates with homocysteine levels. Int J Mol Sci 21(1):314","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1766_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3109\/09513590.2013.864270","volume":"30","author":"A Kara","year":"2014","unstructured":"Kara A et al (2014) Ultra-structural changes and apoptotic activity in cerebellum of post-menopausal-diabetic rats: a histochemical and ultra-structural study. Gynecol Endocrinol 30(3):226\u2013231","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"1766_CR61","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","volume":"18","author":"M Hamaguchi","year":"2012","unstructured":"Hamaguchi M et al (2012) Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol 18(3):237\u2013243","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1766_CR62","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/1871530318666180423101755","volume":"18","author":"N Veronese","year":"2018","unstructured":"Veronese N et al (2018) Menopause does not affect fatty liver severity in women: a population study in a Mediterranean area. Endocr Metab Immune Disord Drug Targets 18(5):513\u2013521","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"1766_CR63","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12902-019-0427-7","volume":"19","author":"H Zhou","year":"2019","unstructured":"Zhou H et al (2019) Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China. BMC Endocr Disord 19(1):98","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"1766_CR64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/hep.28514","volume":"64","author":"JS Klair","year":"2016","unstructured":"Klair JS et al (2016) A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology 64(1):85\u201391","journal-title":"Hepatology"},{"issue":"4","key":"1766_CR65","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.26761","volume":"59","author":"JD Yang","year":"2014","unstructured":"Yang JD et al (2014) Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 59(4):1406\u20131414","journal-title":"Hepatology"},{"issue":"5","key":"1766_CR66","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/hep.27097","volume":"60","author":"M Yoneda","year":"2014","unstructured":"Yoneda M et al (2014) The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease. Hepatology 60(5):1792","journal-title":"Hepatology"},{"issue":"9","key":"1766_CR67","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.cgh.2014.12.033","volume":"13","author":"M Lazo","year":"2015","unstructured":"Lazo M et al (2015) Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis. Clin Gastroenterol Hepatol 13(9):1686\u20131693","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1766_CR68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF03401306","volume":"12","author":"SA Polyzos","year":"2013","unstructured":"Polyzos SA et al (2013) Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease. Hormones (Athens) 12(3):405\u2013416","journal-title":"Hormones (Athens)"},{"issue":"4","key":"1766_CR69","doi-asserted-by":"publisher","first-page":"e2621","DOI":"10.1097\/MD.0000000000002621","volume":"95","author":"N Wang","year":"2016","unstructured":"Wang N et al (2016) Combined association of vitamin d and sex hormone binding globulin with nonalcoholic fatty liver disease in men and postmenopausal women: a cross-sectional study. Medicine (Baltimore) 95(4):e2621","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1766_CR70","first-page":"287","volume":"46","author":"M Flechtner-Mors","year":"2014","unstructured":"Flechtner-Mors M et al (2014) Associations of fatty liver disease and other factors affecting serum SHBG concentrations: a population based study on 1657 subjects. Horm Metab Res 46(4):287\u2013293","journal-title":"Horm Metab Res"},{"issue":"4","key":"1766_CR71","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1210\/jc.2012-3780","volume":"98","author":"W Rosner","year":"2013","unstructured":"Rosner W et al (2013) Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab 98(4):1376\u20131387","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1766_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s42000-018-0012-x","volume":"17","author":"E Chartampilas","year":"2018","unstructured":"Chartampilas E (2018) Imaging of nonalcoholic fatty liver disease and its clinical utility. Hormones (Athens) 17(1):69\u201381","journal-title":"Hormones (Athens)"},{"issue":"3","key":"1766_CR73","doi-asserted-by":"publisher","first-page":"dgz244","DOI":"10.1210\/clinem\/dgz244","volume":"105","author":"X Wang","year":"2020","unstructured":"Wang X et al (2020) Serum SHBG is associated with the development and regression of nonalcoholic fatty liver disease: a prospective study. J Clin Endocrinol Metab 105(3):dgz244","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1766_CR74","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2174\/1570161116666180711121949","volume":"17","author":"V Venetsanaki","year":"2019","unstructured":"Venetsanaki V, Polyzos SA (2019) Menopause and non-alcoholic fatty liver disease: a review focusing on therapeutic perspectives. Curr Vasc Pharmacol 17(6):546\u2013555","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"1766_CR75","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2337\/db11-0727","volume":"61","author":"R Simo","year":"2012","unstructured":"Simo R et al (2012) Potential role of tumor necrosis factor-alpha in downregulating sex hormone-binding globulin. Diabetes 61(2):372\u2013382","journal-title":"Diabetes"},{"key":"1766_CR76","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12986-018-0313-8","volume":"15","author":"J Luo","year":"2018","unstructured":"Luo J et al (2018) Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond) 15:79","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"1766_CR77","first-page":"92","volume":"42","author":"SA Polyzos","year":"2017","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2017) Adipose tissue, obesity and non-alcoholic fatty liver disease. Minerva Endocrinol 42(2):92\u2013108","journal-title":"Minerva Endocrinol"},{"key":"1766_CR78","doi-asserted-by":"publisher","first-page":"294278","DOI":"10.1155\/2015\/294278","volume":"2015","author":"M Shen","year":"2015","unstructured":"Shen M, Shi H (2015) Sex hormones and their receptors regulate liver energy homeostasis. Int J Endocrinol 2015:294278","journal-title":"Int J Endocrinol"},{"issue":"12","key":"1766_CR79","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/diacare.19.12.1399","volume":"19","author":"H Larsson","year":"1996","unstructured":"Larsson H, Ahren B (1996) Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women. Diabetes Care 19(12):1399\u20131403","journal-title":"Diabetes Care"},{"key":"1766_CR80","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.37.GP.04.04","author":"N Nikolaou","year":"2015","unstructured":"Nikolaou N et al (2015) Regulation of lipogenesis in human hepatocytes by androgens, glucocorticoids, and 5[alpha]-reductase. Endocr Abstr. https:\/\/doi.org\/10.1530\/endoabs.37.GP.04.04","journal-title":"Endocr Abstr"},{"key":"1766_CR81","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.freeradbiomed.2020.02.016","volume":"150","author":"BM Galmes-Pascual","year":"2020","unstructured":"Galmes-Pascual BM et al (2020) 17beta-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance. Free Radic Biol Med 150:148\u2013160","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1766_CR82","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/JOE-16-0350","volume":"232","author":"BM Galmes-Pascual","year":"2017","unstructured":"Galmes-Pascual BM et al (2017) 17beta-estradiol improves hepatic mitochondrial biogenesis and function through PGC1B. J Endocrinol 232(2):297\u2013308","journal-title":"J Endocrinol"},{"issue":"2","key":"1766_CR83","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2337\/db11-1718","volume":"62","author":"L Zhu","year":"2013","unstructured":"Zhu L et al (2013) Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes 62(2):424\u2013434","journal-title":"Diabetes"},{"issue":"16","key":"1766_CR84","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1038\/s41388-018-0631-3","volume":"38","author":"E Cortes","year":"2019","unstructured":"Cortes E et al (2019) Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor. Oncogene 38(16):2910\u20132922","journal-title":"Oncogene"},{"issue":"12","key":"1766_CR85","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1136\/gut.2004.053728","volume":"54","author":"T Itagaki","year":"2005","unstructured":"Itagaki T et al (2005) Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 54(12):1782\u20131789","journal-title":"Gut"},{"issue":"1","key":"1766_CR86","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","volume":"65","author":"J McKenzie","year":"2006","unstructured":"McKenzie J et al (2006) Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin Endocrinol (Oxf) 65(1):40\u201344","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1766_CR87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1590\/S0004-28032013000200032","volume":"50","author":"GS Florentino","year":"2013","unstructured":"Florentino GS et al (2013) Nonalcoholic fatty liver disease in menopausal women. Arq Gastroenterol 50(3):180\u2013185","journal-title":"Arq Gastroenterol"},{"issue":"1","key":"1766_CR88","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cgh.2016.07.034","volume":"15","author":"JD Yang","year":"2017","unstructured":"Yang JD et al (2017) Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 15(1):127\u2013131","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1766_CR89","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2214\/ajr.180.1.1800129","volume":"180","author":"M Nishino","year":"2003","unstructured":"Nishino M et al (2003) Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR Am J Roentgenol 180(1):129\u2013134","journal-title":"AJR Am J Roentgenol"},{"issue":"7497","key":"1766_CR90","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","volume":"330","author":"S Bruno","year":"2005","unstructured":"Bruno S et al (2005) Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. BMJ 330(7497):932","journal-title":"BMJ"},{"issue":"3","key":"1766_CR91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.clbc.2016.12.004","volume":"17","author":"M Yan","year":"2017","unstructured":"Yan M et al (2017) The relationship between tamoxifen-associated nonalcoholic fatty liver disease and the prognosis of patients with early-stage breast cancer. Clin Breast Cancer 17(3):195\u2013203","journal-title":"Clin Breast Cancer"},{"key":"1766_CR92","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejca.2017.05.002","volume":"82","author":"N Hong","year":"2017","unstructured":"Hong N et al (2017) Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: a propensity score-matched cohort study. Eur J Cancer 82:103\u2013114","journal-title":"Eur J Cancer"},{"issue":"8","key":"1766_CR93","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1634\/theoncologist.2018-0370","volume":"24","author":"JI Lee","year":"2019","unstructured":"Lee JI et al (2019) Aromatase inhibitors and newly developed nonalcoholic fatty liver disease in postmenopausal patients with early breast cancer: a propensity score-matched cohort study. Oncologist 24(8):e653\u2013e661","journal-title":"Oncologist"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01766-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01766-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01766-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T10:02:44Z","timestamp":1659952964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01766-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":93,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["1766"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01766-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been approved by the Ethics department of the Aretaieio Hospital, National and Kapodistrian University of Athens.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this type of study, consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}